Results 151 to 160 of about 84,841 (279)

A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Hepatoid adenocarcinoma (HAC) is a rare extrahepatic tumor of non‐germ cell origin that morphologically resembles hepatocellular carcinoma (HCC). HAC has a propensity to metastasize to the liver and therefore may be mistaken for HCC. There is a lack of standardized treatment protocols, and further studies are needed to evaluate the benefit of ...
Christina Liava   +4 more
wiley   +1 more source

Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population‐Based Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Aims Clear cell adenocarcinoma of the cervix (CCAC) is a rare and aggressive malignancy with poor prognosis. This study aimed to develop and validate nomograms and risk‐stratification scores for predicting overall survival (OS) and cancer‐specific survival (CSS) in CCAC patients.
Lijun Chen   +5 more
wiley   +1 more source

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma. [PDF]

open access: yesNat Commun
Nassar AH   +73 more
europepmc   +2 more sources

Nipple‐Originating Solid Papillary Carcinoma In Situ: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Solid papillary carcinoma of the breast is a rare histopathological subtype of papillary neoplasms, and its in situ variant localized to the nipple is particularly uncommon. Current oncology literature provides limited evidence on standardized diagnostic criteria, biological behavior, and optimal treatment strategies for this entity.
Yuying Yang   +4 more
wiley   +1 more source

Merkel Cell Carcinoma: A Complete Response to Avelumab Immunotherapy

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Merkel cell carcinoma is an aggressive form of cancer with poor prognosis, particularly for individuals deemed unsuitable for surgical resection. With new immunotherapy agents being used alone or as an adjuvant treatment, improving long term outcomes are being seen, even for those deemed to be treated with palliative intent.
Eamonn Byrne   +3 more
wiley   +1 more source

CT and MRI Manifestations of Pancreatic Hemangioma: A Literature Review and a New Case Report

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Pancreatic hemangioma is an extremely rare benign tumor occurring in the pancreas. Preoperative diagnosis is challenging due to its lack of specificity in clinical manifestations and imaging examinations. A pancreatic lesion was found during physical examination of a 54‐year‐old woman who had no symptoms of abdominal discomfort.
Jing Zhang   +3 more
wiley   +1 more source

Unexplained Hyponatremia Revealing Vitamin D Deficiency: A Clinical Case Report

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT “SIAD” (syndrome of inappropriate antidiuresis) is frequently encountered in clinical practice, often necessitating the exclusion of various differential diagnoses and involving expensive treatments. In cases of SIAD concomitant with vitamin D deficiency, treatment with vitamin D supplementation may not only correct hyponatremia but also ...
Sara Yavuz Ileri
wiley   +1 more source

A Case of Large Cell Neuroendocrine Carcinoma of the Bladder With Long-Term Control by Metastasectomy. [PDF]

open access: yesIJU Case Rep
Takaoka N   +8 more
europepmc   +1 more source

Beyond bacterial defences: the role of lysozyme in cancer

open access: yesClinical and Translational Medicine, Volume 16, Issue 2, February 2026.
Lysozyme (LYZ) is a multi‐functional secreted factor that encompasses both antibacterial and immunomodulatory functions. Emerging evidence highlights its complex role in tumour progression by directly influencing tumour cells and modulating the immune microenvironment.
Lei Wang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy